Publication | Closed Access

Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction

UrologyErectile DysfunctionIntranasal Pt-141Placebo-controlled EvaluationPharmacologySexual DysfunctionPharmacotherapyMild-to-moderate Erectile DysfunctionMedicine